Angiomotin and angiostatin as asthma biomarkers: Implications for the regulation of airway remodeling and inflammation
Allergy · 2023
DOI: 10.1111/all.15637 ↗Kurz gefasst
Leserbrief in der Zeitschrift Allergy, 2023. Verfasst von Pureun-Haneul Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea. Hauptthemen laut MEDLINE: Angiostatins, Asthma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
ORCID-Profile: Pureun-Haneul Lee, SeonMuk Choi, MinHyeok An, DaYeon Hwang, Shinhee Park, Ae Rin Baek, An-Soo Jang
Zitieren
APA
Lee, P. H., Choi, S., An, M., Hwang, D., Park, S., Baek, A. R., & Jang, A. S. (2023). Angiomotin and angiostatin as asthma biomarkers: Implications for the regulation of airway remodeling and inflammation. Allergy. https://doi.org/10.1111/all.15637
Vancouver
Lee PH, Choi S, An M, Hwang D, Park S, Baek AR, et al. Angiomotin and angiostatin as asthma biomarkers: Implications for the regulation of airway remodeling and inflammation. Allergy. 2023. doi:10.1111/all.15637
BibTeX
@article{Lee2023,
author = {Lee, Pureun-Haneul and Choi, SeonMuk and An, MinHyeok and Hwang, DaYeon and Park, Shinhee and Baek, Ae Rin and Jang, An-Soo},
title = {Angiomotin and angiostatin as asthma biomarkers: Implications for the regulation of airway remodeling and inflammation},
journal = {Allergy},
year = {2023},
doi = {10.1111/all.15637}
}
EUVIMED